Investing in Sexual Health Would Save 1.5 Million Lives a Year
Tuesday, 03 February 2004
LONDON (Agence de Presse Medicale for Reuters Health) - Millions of lives could be saved by increased investment in contraceptive services, according to a report released on Tuesday by the United Nations Population Fund and the Alan Guttmacher Institute.
read more
|
Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic Procedures
Thursday, 08 January 2004
BERKELEY, CA (UroToday Inc.) - Postmenopausal women taking unopposed estrogen have historically been thought to be at risk for developing gynecologic malignancies.
read more
|
Association of Funding and Conclusions in Randomized Drug Trials
Thursday, 08 January 2004
BERKELEY, CA (UroToday Inc.) - Past studies have suggested that industry sponsored trials tend to draw conclusions supporting the use of the industry drug.
read more
|
Risk-Benefit Ratio Speaks Against Estrogen Plus Progestin Therapy to Decrease Fracture Risk or Improve Bone Mineral Density
Thursday, 08 January 2004
BERKELEY, CA (UroToday Inc.) - The Women's Health Initiative (WHI) trial, completed in July 2002, was designed to determine the effects of estrogen-plus-progestin on a number of chronic diseases including the risk of osteoporotic fractures and bone mineral density.
read more
|
Hormone Replacement Drug Use Tumbles, Study Says
Tuesday, 06 January 2004
CHICAGO (Reuters) - Studies showing that hormone replacement therapy raises the risk of heart disease, cancer and blood clots have knocked U.S. prescriptions for the drugs back to where they were nine years ago, a report said on Tuesday.
read more
|
Long-term Results of Sacrohysteropexy for Uterovaginal Prolapse 'Excellent'
Wednesday, 31 December 2003
NEW YORK (Reuters Health) - Abdominal sacrohysteropexy is safe and effective for the treatment of young women with uterovaginal prolapse, according to a retrospective study with an average of 8 years follow-up.
read more
|
Pelvic Floor Exercises May Not Improve Postpartum Incontinence
Monday, 08 December 2003
NEW YORK (Reuters Health) - US researchers have identified several factors that are associated with an increased risk of urinary incontinence in the 12-month postpartum period, according to a new report.
read more
|
FDA Approves Once-Daily Cipro XR for the Treatment of Complicated Urinary Tract Infections (cUTIs)
Thursday, 28 August 2003
WEST HAVEN, Conn., Aug. 28, 2003 /PRNewswire/ -- Bayer Pharmaceuticals Corporation announced today that the U.S. Food and Drug Administration (FDA) has approved a once-daily formulation of Cipro(R) XR (ciprofloxacin* extended-release tablets) for the treatment of complicated urinary tract infections (cUTIs) and acute uncomplicated pyelonephritis (AUP), or kidney infection. The new formulation can be taken once a day for 7-14 days at a dose of 1000mg.
read more
|
Botox Relieves Voiding Dysfunction Due to Benign Prostatic Hypertrophy
Tuesday, 26 August 2003
NEW YORK (Reuters Health) - Injection of botulinum toxin (Botox) into the prostate appears to be a safe and effective treatment for voiding dysfunction due to benign prostatic hyperplasia (BPH), Italian investigators report.
read more
|
Arginine Vasopressin and Nocturnal Polyuria Appear not to Be Significantly Related in Older Adults
Wednesday, 13 August 2003
BERKELEY, CA (UroToday Inc.) - Dr. T.M. Johnson II and colleagues studied 45 older adults at home and in their Clinical Research Center (CRC) with the goal of determining whether their nocturnal polyuria could be associated with abnormal arginine vasopressin (AVP) release or action. It increases during normal sleep, presumably in response to water deprivation. Since AVP increases water retention, decreases urine production and increases urine osmolality, decreased nighttime excretion may contribute to nocturia.
read more
|
Drop in Estrogen Replacement Use Follows WHI Trial Results
Tuesday, 24 June 2003
NEW YORK (Reuters Health) - Adverse effects linked to hormone replacement in a major study last year appear to have triggered a sharp drop in the number of older women using estrogen replacement therapy (ERT), according to a research letter published in the June 25th issue of the Journal of the American Medical Association.
read more
|
Ovarian Vein Reflux: Underdiagnosed and Undertreated
Thursday, 19 June 2003
NEW YORK (Reuters Health) - Physicians should include ovarian vein reflux in the differential diagnosis of women with pelvic pain, investigators said at a Radiological Society of North America briefing here on Thursday.
read more
|
Lymphadenectomy May be Unnecessary for Some Endometrial Cancer Patients
Wednesday, 28 May 2003
NEW YORK (Reuters Health) - Para-aortic lymphadenectomy may be unnecessary in endometrial carcinoma patients without risk factors for para-aortic lymph node metastasis, according to the results of a study published in the May issue of the American Journal of Obstetrics and Gynecology.
read more
|
Pre-Emptive Analgesia Fails to Reduce Opioid Needs Following Gynecologic Surgery
Friday, 23 May 2003
NEW YORK (Reuters Health) - In women undergoing gynecologic surgery through a midline vertical incision, injecting the proposed site with local anesthetic before making the incision does not decrease postoperative opioid use, according to a recent report.
read more
|
Watson Pharma First-Quarter Profit Rises
Tuesday, 06 May 2003
Tuesday May 6, 11:05 am ET NEW YORK, May 6 (Reuters) - Watson Pharmaceuticals Inc. (NYSE:WPI - News) on Tuesday reported higher first-quarter profit on sales of women's health-care treatments and newly marketed medicines.
read more
|
Female Urology 
